New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 13, 2014
04:55 EDTCGIX, CGIX, CGIX, HART, HART, HART, NURO, NURO, NURO, CANF, CANF, CANF, AMBS, AMBS, AMBS, AGEN, AGEN, AGEN, AVXL, AVXL, AVXL, SYN, SYN, SYN, CEMI, CEMI, CEMI, SRNE, SRNE, SRNE, OXBT, OXBT, OXBTOneMedPlace to hold a forum
7th Annual OneMedForum SF 2014 is being held in San Francisco on January 13-15.
News For CGIX;SRNE;CEMI;SYN;AVXL;AGEN;AMBS;CANF;NURO;HART;OXBT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 5, 2016
08:32 EDTAMBSAmarantus Bioscience requests RPDD from FDA for retinitis pigmentosa
Subscribe for More Information
08:04 EDTCGIXCancer Genetics signs new agreement with Blue Cross Blue Shield of Minnesota
Subscribe for More Information
February 2, 2016
07:00 EDTSYNSynthetic Biologics reports results of third party analysis of Trimesta trial
Subscribe for More Information
January 29, 2016
13:19 EDTSYNOptions with increasing call volume: EXP FLIR SYN INO PBR VMEM EPI GILD EA
Subscribe for More Information
January 28, 2016
07:08 EDTNURONeuroMetrix says primary initiative for 2016 is launch of Quell
Subscribe for More Information
07:07 EDTNURONeuroMetrix reports Q4 revenue $2.74M, one estimate $2.38M
Subscribe for More Information
January 26, 2016
08:53 EDTCEMIChembio Diagnostics to sell Sure Check HIV 1/2 Assay in U.S. on June 1
Subscribe for More Information
January 25, 2016
07:51 EDTSRNESorrento Therapeutics should be bought aggressively, says Brean Capital
Brean Capital said they would be aggressive buyers of Sorrento Therapeutics following the recent release of top-line Phase lll data for biosimilar antibodies of Eribtux and Remicade. The firm sees upside from the biosimilar products and possibility of a BD deal with an established U.S. based biotech company in the near-term. Brean Capital reiterated its Buy rating and $15 price target on Sorrento Therapeutics shares.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use